Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines

Pedro Berraondo, Raquel Cuesta, Miguel F. Sanmamed, Ignacio Melero

View at source ↗Article14 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1158/2159-8290.cd-24-1196
Published
Nov 1, 2024
Venue
Cancer Discovery
DOI
10.1158/2159-8290.cd-24-1196
PubMed
39485256
Categories
Immunotherapy and Immune Responses
Provenance
openalex

Topics